— Know what they know.
Not Investment Advice
Also trades as: ENDPQ (OTC) · $vol 0M · 0Y5F.L (LSE) · $vol 0M

ENDP NASDAQ

Endo International plc
1W: -27.9% 1M: -35.1% 3M: -26.4% 1Y: -88.4% 3Y: -90.0% 5Y: -96.5%
$0.37
Last traded 2022-08-25 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Cash Flow Trends

Operating Cash Flow
$411M +3.4% ▲
5Y CAGR: -4.8%
Capital Expenditures
$78M +89.2% ▲
5Y CAGR: -13.2%
Free Cash Flow
$333M +202.8% ▲
5Y CAGR: -1.9%
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$246M +173.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2017FY2018FY2019FY2020FY2021
— Operating Activities —
Net Income-$2.0B-$1.0B-$423M$184M-$569M
Depreciation & Amort.$984M$724M$613M$519M$457M
Stock-Based Comp.$50M$54M$59M$41M$30M
Change in Working Capital$448M-$397M-$518M-$348M$85M
Other Non-Cash Items$1.3B$912M$372M$165M$411M
Operating Cash Flow$554M$267M$98M$397M$411M
— Investing Activities —
Capital Expenditures-$126M-$86M-$64M-$721M-$78M
Acquisitions (Net)$223M$70M$7M$7M-$5M
Investment Purchases$0$0$0$721M$0
Investment Sales$7M$0$0$93M$0
Other Investing$0-$2M-$3M-$724M$23M
Investing Cash Flow$105M-$18M-$60M-$625M-$60M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0-$5M-$10M$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$167M-$82M$205M-$109M-$105M
Financing Cash Flow-$167M-$82M$205M-$109M-$105M
Net Change in Cash$506M$166M$244M-$335M$246M
Cash End of Period$1.3B$1.5B$1.7B$1.4B$1.6B
Free Cash Flow$428M$181M$34M-$324M$333M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms